Valuation: DEEPVERGE

Market Cap 8.75M 7.72M 7.3M 6.62M 12.42M 839M 12.54M 87.6M 33.76M 429M 32.84M 32.12M 1.38B P/E 2020
-12.5x
P/E 2021 -19.3x
Enterprise Value 9.18M 8.1M 7.66M 6.95M 13.03M 881M 13.16M 91.95M 35.44M 450M 34.47M 33.72M 1.45B EV / Sales 2020
10x
EV / Sales 2021 6.11x
Free-Float
90.54%
Yield 2020 *
-
Yield 2021 -
5 years 0
Extreme 0.0005
0.34
10 years 0
Extreme 0.0005
0.42
Manager TitleAgeSince
Chief Executive Officer 68 2022-10-31
Director of Finance/CFO - 2018-08-29
Sales & Marketing 52 2021-07-11
Director TitleAgeSince
Chairman 66 2019-05-20
Director/Board Member 68 2020-11-09
Date Insider Type Main position Quantity % Market Cap. Importance
11/16/22 Free

Executive/Senior Manager

162,500 0.0740%
11/16/22 Buy

Chief Financial Officer

2,000,000 0.9103%
11/16/22 Buy

Executive/Senior Manager

650,000 0.2958%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 421K
-0.60%-0.49%+13.89%+22.57% 22.33B
+0.19%-2.60%-7.48% - 13.11B
-1.23%-7.60%+5.67%-27.14% 3.41B
+3.17%-8.30%+24.61%+46.43% 3.21B
+0.39%+0.31%-27.41%-35.65% 1.95B
-3.09%-8.34%-40.67% - 1.85B
-2.00%+3.40%-4.44%+18.46% 1.62B
+2.05%-4.03%+85.29%+115.18% 1.55B
+0.69%-1.40%-29.10%+6.08% 1.31B
Average -0.04%-2.78%+2.04%+18.24% 5.03B
Weighted average by Cap. -0.18%-2.07%+5.34%+20.00%

Financials

2020 2021
Net sales 4.48M 3.96M 3.74M 3.39M 6.36M 430M 6.43M 44.91M 17.31M 220M 16.83M 16.47M 707M 9.3M 8.2M 7.76M 7.04M 13.2M 892M 13.33M 93.13M 35.89M 456M 34.91M 34.15M 1.47B
Net income -2.72M -2.4M -2.27M -2.06M -3.86M -261M -3.9M -27.23M -10.49M -133M -10.21M -9.98M -429M -2.68M -2.36M -2.24M -2.03M -3.8M -257M -3.84M -26.83M -10.34M -131M -10.06M -9.84M -422M
Net Debt 1.11M 982K 929K 843K 1.58M 107M 1.6M 11.15M 4.3M 54.54M 4.18M 4.09M 176M 434K 383K 362K 329K 616K 41.65M 622K 4.35M 1.68M 21.27M 1.63M 1.59M 68.43M
Logo DEEPVERGE
Deepverge PLC is an Ireland-based vertically integrated company. The Company provides core skin and human testing technology. The Company is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.
Employees
73